Markus Sjoblom

Uppsala, C 75105, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant).

The In Vivo Effect of Amorphous Drug Nanoprecipitates on the Intestinal Absorption of the PROTACs ARV-110 (Bavdeglutamide) and ARV-471 (Vepdegestrant).

Journal: Molecular pharmaceutics

Published: May 01, 2026

Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma.

Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma.

Journal: Neoplasia (New York, N.Y.)

Published: April 23, 2026

Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma.

Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma.

Journal: Neoplasia (New York, N.Y.)

Published: April 23, 2026

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling.

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling.

Journal: FEBS open bio

Published: December 09, 2025

Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients.

Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients.

Journal: Therapeutic advances in medical oncology

Published: October 22, 2025

A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma.

A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 18, 2025

Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives.

Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives.

Journal: European journal of pharmacology

Published: June 09, 2025

A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats.

A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: January 01, 2025

Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients.

Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients.

Journal: Therapeutic advances in medical oncology

Published: December 04, 2024

Endoplasmic reticulum stress in the pathogenesis of chemotherapy-induced mucositis: Physiological mechanisms and therapeutic implications.

Endoplasmic reticulum stress in the pathogenesis of chemotherapy-induced mucositis: Physiological mechanisms and therapeutic implications.

Journal: Acta physiologica (Oxford, England)

Published: April 04, 2024

Melatonin mitigates chemotherapy-induced small intestinal atrophy in rats and reduces cytotoxicity in murine intestinal organoids.

Melatonin mitigates chemotherapy-induced small intestinal atrophy in rats and reduces cytotoxicity in murine intestinal organoids.

Journal: PloS one

Published: April 02, 2024

LRBA, a BEACH protein mutated in human immune deficiency, is widely expressed in epithelia, exocrine and endocrine glands, and neurons.

LRBA, a BEACH protein mutated in human immune deficiency, is widely expressed in epithelia, exocrine and endocrine glands, and neurons.

Journal: Scientific reports

Published: January 29, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026